Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design

Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2002-04, Vol.237 (1), p.107-118
Hauptverfasser: Sánchez-Lafuente, Carla, Furlanetto, Sandra, Fernández-Arévalo, Mercedes, Alvarez-Fuentes, Josefa, Rabasco, Antonio M., Faucci, M.Teresa, Pinzauti, Sergio, Mura, Paola
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 118
container_issue 1
container_start_page 107
container_title International journal of pharmaceutics
container_volume 237
creator Sánchez-Lafuente, Carla
Furlanetto, Sandra
Fernández-Arévalo, Mercedes
Alvarez-Fuentes, Josefa
Rabasco, Antonio M.
Faucci, M.Teresa
Pinzauti, Sergio
Mura, Paola
description Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles.
doi_str_mv 10.1016/S0378-5173(02)00028-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71607090</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517302000285</els_id><sourcerecordid>71607090</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-4e77fae8086869e55e6e9bac111658d633d9c0f545febfa0e17db01a348b7bb03</originalsourceid><addsrcrecordid>eNqFkMtuFDEQRS0EIpPAJ4B6A4JFgz0eP5oNQgkvKRILYG257XJk1G0PLncIfD3uzIgsWVnXOnWrdAh5wugrRpl8_ZVypXvBFH9Bty8ppduW7pEN04r3fKfkfbL5h5yQU8QfDZJbxh-SE8YGITQdNuTXRfQ2ZYwJOripkDz4vsAEFqGbbS3xpqt2nKDimy7va5zjH1tjTl0OXchlXqZDvLYlrhx2Syu76rC2f6zR2akV76HEGVJtwQPGq_SIPAh2Qnh8fM_I9w_vv51_6i-_fPx8_u6yd3xgtd-BUsGCplpqOYAQIGEYrWOMSaG95NwPjgaxEwHGYCkw5UfKLN_pUY0j5Wfk-aF3X_LPBbCaOaKDabIJ8oJGMUkVHVZQHEBXMmKBYPbtZFt-G0bNatzcGjerTkO35ta4EW3u6XHBMs7g76aOihvw7AhYbDJCsclFvOO4ZJzqtejtgYOm4zpCMegiJAc-FnDV-Bz_c8pfqt6gzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71607090</pqid></control><display><type>article</type><title>Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sánchez-Lafuente, Carla ; Furlanetto, Sandra ; Fernández-Arévalo, Mercedes ; Alvarez-Fuentes, Josefa ; Rabasco, Antonio M. ; Faucci, M.Teresa ; Pinzauti, Sergio ; Mura, Paola</creator><creatorcontrib>Sánchez-Lafuente, Carla ; Furlanetto, Sandra ; Fernández-Arévalo, Mercedes ; Alvarez-Fuentes, Josefa ; Rabasco, Antonio M. ; Faucci, M.Teresa ; Pinzauti, Sergio ; Mura, Paola</creatorcontrib><description>Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/S0378-5173(02)00028-5</identifier><identifier>PMID: 11955809</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Anti-HIV Agents - chemistry ; Anti-HIV Agents - pharmacokinetics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; Chemistry, Pharmaceutical ; Delayed-Action Preparations - chemistry ; Delayed-Action Preparations - pharmacokinetics ; Didanosine ; Didanosine - chemistry ; Didanosine - pharmacokinetics ; Extended-release inert matrix tablets ; General pharmacology ; Medical sciences ; Models, Statistical ; Multiple response optimization ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Response surface methodology ; Statistical experimental design ; Tablets - chemistry ; Tablets - pharmacokinetics</subject><ispartof>International journal of pharmaceutics, 2002-04, Vol.237 (1), p.107-118</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-4e77fae8086869e55e6e9bac111658d633d9c0f545febfa0e17db01a348b7bb03</citedby><cites>FETCH-LOGICAL-c391t-4e77fae8086869e55e6e9bac111658d633d9c0f545febfa0e17db01a348b7bb03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0378-5173(02)00028-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13613085$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11955809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez-Lafuente, Carla</creatorcontrib><creatorcontrib>Furlanetto, Sandra</creatorcontrib><creatorcontrib>Fernández-Arévalo, Mercedes</creatorcontrib><creatorcontrib>Alvarez-Fuentes, Josefa</creatorcontrib><creatorcontrib>Rabasco, Antonio M.</creatorcontrib><creatorcontrib>Faucci, M.Teresa</creatorcontrib><creatorcontrib>Pinzauti, Sergio</creatorcontrib><creatorcontrib>Mura, Paola</creatorcontrib><title>Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles.</description><subject>Anti-HIV Agents - chemistry</subject><subject>Anti-HIV Agents - pharmacokinetics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical</subject><subject>Delayed-Action Preparations - chemistry</subject><subject>Delayed-Action Preparations - pharmacokinetics</subject><subject>Didanosine</subject><subject>Didanosine - chemistry</subject><subject>Didanosine - pharmacokinetics</subject><subject>Extended-release inert matrix tablets</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Models, Statistical</subject><subject>Multiple response optimization</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Response surface methodology</subject><subject>Statistical experimental design</subject><subject>Tablets - chemistry</subject><subject>Tablets - pharmacokinetics</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtuFDEQRS0EIpPAJ4B6A4JFgz0eP5oNQgkvKRILYG257XJk1G0PLncIfD3uzIgsWVnXOnWrdAh5wugrRpl8_ZVypXvBFH9Bty8ppduW7pEN04r3fKfkfbL5h5yQU8QfDZJbxh-SE8YGITQdNuTXRfQ2ZYwJOripkDz4vsAEFqGbbS3xpqt2nKDimy7va5zjH1tjTl0OXchlXqZDvLYlrhx2Syu76rC2f6zR2akV76HEGVJtwQPGq_SIPAh2Qnh8fM_I9w_vv51_6i-_fPx8_u6yd3xgtd-BUsGCplpqOYAQIGEYrWOMSaG95NwPjgaxEwHGYCkw5UfKLN_pUY0j5Wfk-aF3X_LPBbCaOaKDabIJ8oJGMUkVHVZQHEBXMmKBYPbtZFt-G0bNatzcGjerTkO35ta4EW3u6XHBMs7g76aOihvw7AhYbDJCsclFvOO4ZJzqtejtgYOm4zpCMegiJAc-FnDV-Bz_c8pfqt6gzA</recordid><startdate>20020426</startdate><enddate>20020426</enddate><creator>Sánchez-Lafuente, Carla</creator><creator>Furlanetto, Sandra</creator><creator>Fernández-Arévalo, Mercedes</creator><creator>Alvarez-Fuentes, Josefa</creator><creator>Rabasco, Antonio M.</creator><creator>Faucci, M.Teresa</creator><creator>Pinzauti, Sergio</creator><creator>Mura, Paola</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020426</creationdate><title>Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design</title><author>Sánchez-Lafuente, Carla ; Furlanetto, Sandra ; Fernández-Arévalo, Mercedes ; Alvarez-Fuentes, Josefa ; Rabasco, Antonio M. ; Faucci, M.Teresa ; Pinzauti, Sergio ; Mura, Paola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-4e77fae8086869e55e6e9bac111658d633d9c0f545febfa0e17db01a348b7bb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Anti-HIV Agents - chemistry</topic><topic>Anti-HIV Agents - pharmacokinetics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical</topic><topic>Delayed-Action Preparations - chemistry</topic><topic>Delayed-Action Preparations - pharmacokinetics</topic><topic>Didanosine</topic><topic>Didanosine - chemistry</topic><topic>Didanosine - pharmacokinetics</topic><topic>Extended-release inert matrix tablets</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Models, Statistical</topic><topic>Multiple response optimization</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Response surface methodology</topic><topic>Statistical experimental design</topic><topic>Tablets - chemistry</topic><topic>Tablets - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Lafuente, Carla</creatorcontrib><creatorcontrib>Furlanetto, Sandra</creatorcontrib><creatorcontrib>Fernández-Arévalo, Mercedes</creatorcontrib><creatorcontrib>Alvarez-Fuentes, Josefa</creatorcontrib><creatorcontrib>Rabasco, Antonio M.</creatorcontrib><creatorcontrib>Faucci, M.Teresa</creatorcontrib><creatorcontrib>Pinzauti, Sergio</creatorcontrib><creatorcontrib>Mura, Paola</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Lafuente, Carla</au><au>Furlanetto, Sandra</au><au>Fernández-Arévalo, Mercedes</au><au>Alvarez-Fuentes, Josefa</au><au>Rabasco, Antonio M.</au><au>Faucci, M.Teresa</au><au>Pinzauti, Sergio</au><au>Mura, Paola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2002-04-26</date><risdate>2002</risdate><volume>237</volume><issue>1</issue><spage>107</spage><epage>118</epage><pages>107-118</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11955809</pmid><doi>10.1016/S0378-5173(02)00028-5</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2002-04, Vol.237 (1), p.107-118
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_71607090
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anti-HIV Agents - chemistry
Anti-HIV Agents - pharmacokinetics
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Biological and medical sciences
Chemistry, Pharmaceutical
Delayed-Action Preparations - chemistry
Delayed-Action Preparations - pharmacokinetics
Didanosine
Didanosine - chemistry
Didanosine - pharmacokinetics
Extended-release inert matrix tablets
General pharmacology
Medical sciences
Models, Statistical
Multiple response optimization
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Response surface methodology
Statistical experimental design
Tablets - chemistry
Tablets - pharmacokinetics
title Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A02%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Didanosine%20extended-release%20matrix%20tablets:%20optimization%20of%20formulation%20variables%20using%20statistical%20experimental%20design&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=S%C3%A1nchez-Lafuente,%20Carla&rft.date=2002-04-26&rft.volume=237&rft.issue=1&rft.spage=107&rft.epage=118&rft.pages=107-118&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/S0378-5173(02)00028-5&rft_dat=%3Cproquest_cross%3E71607090%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71607090&rft_id=info:pmid/11955809&rft_els_id=S0378517302000285&rfr_iscdi=true